Ask Warren

Amicogen

092040 · KOSDAQ · ₩092040 · 아미코젠

₩915▲ ₩1 (0.11%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩13B₩12B₩11B₩10B₩10B₩11B₩57B₩40B
Cost of sales₩10B₩9.7B₩8.8B₩9.6B₩8.8B₩9.3B₩43B₩27B
Gross profit₩2.9B₩2.6B₩2.1B₩556M₩1.4B₩1.5B₩14B₩13B
Operating income−₩1.3B−₩3.2B−₩3.9B−₩4.7B−₩4.2B−₩4.3B−₩802M−₩1.4B
Net income−₩40B₩19B−₩17B−₩7B−₩220M−₩5.8B−₩53B₩11B
Net income to shareholders−₩21B₩20B−₩5.4B−₩13B−₩6B−₩5.7B−₩39B₩931M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩197B₩214B₩232B₩241B₩256B₩274B₩294B₩482B
Current assets₩43B₩44B₩38B₩43B₩55B₩69B₩88B₩152B
Cash and equivalents₩8.2B₩6.7B₩6.2B₩5.8B₩22B₩16B₩6.1B₩13B
Total liabilities₩78B₩80B₩136B₩139B₩146B₩156B₩171B₩264B
Current liabilities₩41B₩41B₩81B₩79B₩80B₩88B₩99B₩166B
Borrowings₩31B₩28B₩39B₩84B₩99B₩104B₩111B₩163B
Total equity₩119B₩133B₩96B₩101B₩110B₩117B₩123B₩218B
Shareholders' equity₩118B₩132B₩95B₩101B₩109B₩117B₩122B₩171B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩4.1B−₩3.6B₩1.1B−₩2.2B−₩43B₩20B−₩11B₩5.2B
Capital spending₩78M₩20M₩97M₩877M₩333M₩2.4B₩3.8B₩6.8B
Free cash flow₩4B−₩3.6B₩1B−₩3.1B−₩43B₩17B−₩14B−₩1.6B

Consolidated where available. Amounts in won.

Also known as: Amicogen / 아미코젠 / 092040 / KRX:092040

Source: KRX statistical information